Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue:
Product sales, net of discounts and refunds	$ 1,345,000	$ 167,000	$ 4,817,000	$ 533,000
Consulting research & development income	0	0	52,000	169,000
Shipping and other sales	14,000	25,000	70,000	39,000
Total revenues	1,359,000	192,000	4,939,000	741,000
Cost of goods sold:
Cost of goods solds	512,000	145,000	1,725,000	346,000
Gross profit	847,000	47,000	3,214,000	395,000
Operating expenses:
Research and development expenses	601,000	744,000	1,944,000	2,284,000
Selling, general and administrative expenses	4,584,000	2,075,000	14,925,000	6,711,000
Change in fair value of contingent stock consideration	608,000	0	(947,000)	5,658,000
Total operating expenses	5,793,000	2,819,000	15,922,000	14,653,000
Net operating loss before other income (expense)	(4,946,000)	(2,772,000)	(12,708,000)	(14,258,000)
Other income (expense):
Interest income	2,000	12,000	4,000	32,000
Gain from settlement	0	35,000	2,434,000	61,000
Gain on extinguishment of debt	7,000	0	741,000	0
Loss on sale of property, plant and equipment	0	0	(41,000)	0
Change in fair value of derivative liability	0	13,000	0	88,000
Change in fair value of convertible promissory notes	772,000	0	1,112,000	0
Interest expense	(178,000)	(39,000)	(377,000)	(67,000)
Total other income (expense)	603,000	21,000	3,873,000	114,000
Net loss before income taxes	(4,343,000)	(2,751,000)	(8,835,000)	(14,144,000)
Provision for income taxes	0	0	0	0
Net loss	$ (4,343,000)	$ (2,751,000)	$ (8,835,000)	$ (14,144,000)
Net loss per share
Basic net income per share	$ (0.07)	$ (0.07)	$ (0.18)	$ (0.32)
Diluted net income per share	$ (0.07)	$ (0.07)	$ (0.18)	$ (0.32)
Weighted average common shares outstanding
Basic	62,174,822	41,344,256	49,294,190	43,647,388
Diluted	62,174,822	41,344,256	49,294,190	43,647,388